Author: admin

  • Father’s Tobacco Use May Raise Children’s Diabetes Risk Mouse Study Finds Link Between Father’s Nicotine Exposure and Offspring’s Metabolism

     

    New research from the University of California, Santa Cruz suggests that a father’s nicotine exposure prior to conception may influence how his offspring process sugar, potentially increasing their risk of developing metabolic disorders such as Diabetes.

    The study, published in the Journal of the Endocrine Society, highlights how paternal health behaviors—particularly tobacco and nicotine use—may have long-lasting effects on the next generation.

    Key Findings: Metabolic Changes in Offspring

    Researchers led by Raquel Chamorro-Garcia, professor of microbiology and environmental toxicology, studied lab mice exposed to nicotine through drinking water prior to reproduction. Their offspring showed notable metabolic differences compared to a control group.

    • Female offspring exhibited lower insulin levels and reduced fasting glucose levels
    • Male offspring showed lower fasting blood glucose and altered liver function

    While lower glucose levels are typically considered healthy, the findings suggest impaired liver regulation during fasting—an early sign of metabolic dysfunction associated with conditions like fatty liver disease and diabetes.

    Broader Health Implications

    “Tobacco use in men may increase the likelihood of their children developing chronic diseases,” said Chamorro-Garcia. “This underscores the importance of including male health in preconception care, which is often overlooked.”

    The study also raises concerns about newer nicotine delivery methods, including vaping and nicotine pouches, suggesting that harmful effects may stem from nicotine itself—not just traditional tobacco combustion.

    According to the Centers for Disease Control and Prevention, more than 40 million Americans live with diabetes, a chronic condition linked to serious complications such as heart disease, kidney failure, and nerve damage.

    Implications for Public Health and Prevention

    The findings support growing evidence that reducing modifiable risk factors—such as smoking and nicotine use—before conception may help curb the rising prevalence of metabolic diseases.

    “Limiting nicotine exposure among men could be an important step in addressing the broader diabetes epidemic,” the researchers noted.

    Future Research

    The research team plans to conduct long-term studies to better understand how these metabolic changes evolve as offspring age and whether they directly lead to diabetes development.

    Lead author Stephanie Aguiar emphasized the interdisciplinary nature of the work, noting that the project provided valuable insights into metabolic function and environmental health.

    Funding and Support

    The study, titled “Exposure of Male Mice to Nicotine Leads to Metabolic Dysfunction in their Male and Female Offspring,” was supported by the National Institutes of Health, the National Institute of Environmental Health Sciences, the UC Office of the President Tobacco-Related Disease Research Program, and University of California, Santa Cruz startup funds.

    Business News For Profit

  • Canopy Surpasses 350,000 Lives Protected; Expands Clinical Strategy Team to Accelerate Pre-Escalation Intervention

    SAN FRANCISCO, CA – Apr 1 – Canopy, the category leader in connected safety platforms for U.S. health systems, announced that it now protects more than 350,000 lives nationwide and has expanded itsClinical Strategy Team to further the shift from reactive incident response to proactive, pre-escalation prevention with rich clinical focus and experience.

    As workplace violence, nurse burnout, and staff turnover continue to strain hospital margins, Canopy is investing in deep clinical expertise to provide health systems with the strategies and tools needed for safer daily operations. The expansion includes the addition of Dr. Ryan Oglesby, PhD, MHA, RN, CEN, CFRN, NEA-BC, 2025 National Emergency Nurses Association (ENA) and this year’s Past President, as a Clinical Strategy Director. He joins current Clinical Strategy Director Jeanne Venella, DNP, MS, CEN, CPEN, a nationally recognized expert in clinical operations and patient safety. Together, they strengthen Canopy’s ability to partner directly with executive and nurse leaders on large-scale safety initiatives.

    “At Canopy, we’re turning the commitment to nurse safety into real-world, real-time activation so that bedside caregivers can get help the moment they need it,” said Ryan Oglesby, Clinical Strategy Director. “By growing this clinical strategy team, we are bridging the gap between frontline caregivers and hospital leadership to ensure the protections necessary to keep clinicians focused on taking care of patients.”

    The company’s rapid growth, fueled by its expanding team and recent Series B funding, reflects rising demand from health system leaders who recognize that safety is a critical driver of patient outcomes. Workplace violence drives turnover, increases labor costs, and disrupts productivity. To address these challenges, Canopy is accelerating the evolution of its Connected Safety Platform.

    Over the past six months, Canopy has introduced enhanced mobile responder capabilities across Android and iOS, as well as integrations with Epic, Vocera, and TigerConnect, providing security and clinical teams with immediate, high-fidelity location data. Coupled with advanced reporting and real-time analytics, these updates empower leadership to identify high-risk areas and optimize response protocols.

    In their recent Healthcare Safety Report, which surveyed over 1,000 healthcare workers and leaders, Canopy found that nearly 85% of respondents have experienced at least one workplace violence event in their careers. The report also highlighted a direct link to turnover, with over one-third of workers considering leaving their positions due to safety issues.

    “Our mission is to safeguard healthcare workers wherever they occur across the campus—from the parking garage to the exam room,” said Jeanne Venella, Clinical Strategy Director. “As hospitals move beyond simply reacting to incidents, we are providing the infrastructure for a prevention-first model that strengthens both staff well-being and overall operations.” At the last ENA conference I attended, a nurse approached me in our exhibit hall and stated, “My Canopy button saved my life last week!” Emergency Department Nurse at TJU.

    Canopy’s platform is actively trusted by leading organizations, including the University of Michigan Health-Sparrow and ECU Health. The company will continue expanding its Clinical Strategy Team as part of its long-term commitment to helping health systems protect their people and performance.

    “We knew we couldn’t eliminate workplace violence entirely, but we could certainly prevent the harm coming to our team members. We wanted them to feel empowered, not monitored. Once we rolled [Canopy’s platform] out, you could feel the shift—they finally felt safer.” Chris Nemets, Regional CNIO, University of Michigan Health, states about incorporating Canopy into Michigan Health’s system.

     

  • Häfele Strengthens South India Presence with the Launch of Its New Appliances Studio, Trizone Marketing, in Kochi

    Apr 03: Häfele, a global leader in interior solutions, has strengthened its presence in Kochi with the launch of its new Appliances Studio, further expanding its footprint in Kerala. Located in Vyttila, Kochi, the studio reflects Häfele’s commitment to bringing world-class home solutions closer to customers in a market known for its evolving lifestyle preferences and growing demand for premium interiors.

    Häfele Strengthens South India Presence with the Launch of Its New Appliances Studio, Trizone Marketing, in Kochi

     

    Designed as a dedicated appliances destination, the studio caters to homeowners, architects, and interior designers seeking reliable, high-performance solutions. It serves as an immersive experience centre where customers can engage with Häfele’s appliance solutions through live, hands-on interactions, making the brand’s portfolio more accessible to the Kochi market.

    Spread across 2,000 sq. ft., the studio is among Kerala’s largest appliance galleries. Thoughtfully designed to offer an intuitive and engaging customer journey, it features a live kitchen setup and functional display zones that showcase appliances in real-life usage scenarios. From built-in ovens, microwaves, and combi ovens to hobs, hood solutions, dishwashers, and small domestic appliances, the space allows customers to visualise how each product integrates seamlessly into a complete kitchen environment.

    The studio presents Häfele’s premium range of built-in and small domestic appliances, catering to the growing demand for space-saving designs, refined aesthetics, energy efficiency, and smart functionality. With appliances displayed in live settings, customers can experience products in real time, compare features, and receive expert guidance tailored to their needs.

    “India continues to be a key growth market for Häfele, and our expansion into cities like Kochi reflects our commitment to strengthening customer access to world-class interior and appliance solutions. With the launch of this new Appliances Studio, we aim to create a dedicated experience centre where customers, architects, and designers can explore our integrated offerings and make informed choices. Backed by our strong service network and customer support ecosystem, we remain focused on delivering convenience and enhanced value to our partners and end users across the region,” said Mr. Frank Schloeder, Managing Director, Häfele South Asia.

  • India’s Bioeconomy Enters High-Growth Phase, Eyes $200 Billion Milestone

    India’s Bioeconomy Enters High-Growth Phase, Eyes $200 Billion Milestone

    Pic Credit: Pexel

    India’s bioeconomy is fast emerging as one of the country’s most dynamic growth engines, steadily approaching the $200 billion mark. Fueled by innovation, research, and a thriving startup ecosystem, the sector is redefining how science contributes to economic progress and everyday life.

    From Niche to Mainstream

    Once limited to specialized research and pharmaceuticals, the bioeconomy has expanded into a wide spectrum of industries, including healthcare, agriculture, biofuels, and environmental solutions. This transformation reflects India’s ability to combine scientific expertise with real-world applications, creating solutions that are both scalable and impactful.

    Innovation Driving the Momentum

    At the heart of this growth lies a strong push for innovation. Startups, research institutions, and established companies are working together to develop next-generation technologies in areas such as biotechnology, genomics, and sustainable agriculture.

    Supportive government policies and increased funding have further accelerated this momentum, enabling new ideas to move from laboratories to markets more quickly than ever before.

    Beyond Growth: A Broader Impact

    The rise of the bioeconomy is not just an economic story—it is also about addressing critical challenges. From improving healthcare access to developing climate-resilient crops and clean energy alternatives, the sector is playing a key role in shaping a more sustainable future.

    It is also creating skilled jobs, attracting global investments, and strengthening India’s position as a hub for affordable and innovative solutions.

    Looking Ahead

    As the bioeconomy edges closer to the $200 billion milestone, the focus is shifting toward scaling innovation and deepening collaboration between industry and academia. Strengthening infrastructure and nurturing talent will be crucial to sustaining this growth.

    With strong foundations and growing global relevance, India’s bioeconomy is entering a new phase—one defined by innovation, resilience, and the potential to make a lasting impact on both the economy and society.

  • Helen H. Hobbs, M.D., honored for innovation in cardiovascular science

    Dallas, Apr 03: Helen H. Hobbs, M.D., Professor in the Eugene McDermott Center for Human Growth and Development and of Internal Medicine and Molecular Genetics at UT Southwestern Medical Center, has been named the recipient of the 2026 Valentin Fuster Award for Innovation in Science by the American College of Cardiology (ACC). This honor reflects her contributions to cardiovascular science and her role in advancing research that has directly improved patient care.

    Dr. Hobbs was honored with other 2026 Distinguished Award recipients at the ACC’s Annual Scientific Session on March 28-30 in New Orleans.

    “I am deeply grateful to the American College of Cardiology for this recognition,” Dr. Hobbs said. “I share this award with my scientific partner, Jonathan Cohen, and the many trainees and colleagues who have made our discoveries possible, and with UT Southwestern, which has provided an extraordinary environment for curiosity-driven research that ultimately benefits patients.”

    The Valentin Fuster Award for Innovation in Science, established in 2022, is presented to an investigator who has made significant and sustained contributions to cardiovascular medicine through scientific discovery, innovation in the delivery of science, and leadership in advancing research to improve patient outcomes worldwide.

    “I am honored to recognize Helen Hobbs, M.D., with the Valentin Fuster Award for Innovation in Science,” said Christopher M. Kramer, M.D., FACC, President of the ACC. “Dr. Hobbs has demonstrated remarkable work that will bolster the ACC’s mission to transform cardiovascular care and improve heart health for all.”

    A UTSW physician-scientist since 1987, Dr. Hobbs is an internationally renowned researcher who has used human genetics to identify key proteins and pathways in lipid metabolism. Her work has had far-reaching implications for prevention and treatment of both cardiovascular and metabolic liver disease. Dr. Hobbs’ innovative research has focused on identifying genetic variants that protect against disease rather than those that cause it.

    After arriving in Dallas in 1980 to train in internal medicine, Dr. Hobbs completed a postdoctoral fellowship in the laboratory of Michael Brown, M.D., and Joseph Goldstein, M.D., whose mentorship helped shape her scientific career. Drs. Brown and Goldstein received the 1985 Nobel Prize in Physiology or Medicine for their discovery of the basic mechanisms of cholesterol metabolism, and their findings led to the development of cholesterol-lowering statin drugs.   

    Dr. Hobbs is best known for her collaboration with Jonathan Cohen, Ph.D., Professor in the Center for Human Nutrition, the Eugene McDermott Center for Human Growth and Development and of Internal Medicine. Their work led to the 2006 discovery of the role of the PCSK9 protein in regulating plasma levels of low-density lipoprotein (LDL, or “bad” cholesterol). They discovered that individuals with mutations that inactivate the PCSK9 gene have much lower plasma levels of LDL-cholesterol and have reduced risk of atherosclerotic cardiovascular disease. This seminal finding paved the way for the development of PCSK9-inhibiting drugs now widely used to treat patients with resistant high cholesterol to reduce the risk of heart disease.

    In 2008, Drs. Hobbs and Cohen identified a variant in the PNPLA3 gene, the first genetic risk factor identified for metabolic-associated steatotic liver disease (MASLD). Subsequent work revealed that the same variant is also associated with alcohol-associated liver disease, expanding our understanding of metabolic liver disorders.

    Much of Dr. Hobbs’ groundbreaking research has drawn on data from the Dallas Heart Study, a large, multiethnic, longitudinal study of cardiovascular disease that she co-founded, together with Ronald Victor, in 2000. The study, now called the Dallas Hearts and Minds Study, gathered detailed clinical evaluations, imaging, and genetic data from thousands of Dallas County residents and has become a model for population-based genetic research worldwide.

    Born in Boston, Dr. Hobbs earned her bachelor’s degree in human biology from Stanford University and her medical degree from Case Western Reserve University School of Medicine. She completed her internal medicine training at Columbia-Presbyterian Medical Center and UT Southwestern, where she was later encouraged by the late Donald Seldin, M.D., longtime Chair of Internal Medicine, to pursue a career in research.

    A member of both the National Academy of Medicine and the National Academy of Sciences as well as a Howard Hughes Medical Institute Investigator, Dr. Hobbs has received numerous national and international honors. These include the Heinrich Wieland Prize in 2005; the international Breakthrough Prize in Life Sciences in 2015; the Institut de France Grand Prix and the Harrington Prize for Innovation in 2018; the Passano Award with Dr. Cohen in 2016 for exemplary research that leads to real-world applications; and the Ross Prize in Molecular Medicine in 2023 with Dr. Cohen for their groundbreaking research in dyslipidemias and metabolic liver disease.

    Dr. Hobbs holds the Dallas Heart Ball Chair in Cardiology Research. Dr. Brown, a Regental Professor, holds The W.A. (Monty) Moncrief Distinguished Chair in Cholesterol and Arteriosclerosis Research and the Paul J. Thomas Chair in Medicine. Dr. Cohen holds the C. Vincent Prothro Distinguished Chair in Human Nutrition Research. Dr. Goldstein, a Regental Professor, holds the Julie and Louis A. Beecherl, Jr. Distinguished Chair in Biomedical Research and the Paul J. Thomas Chair in Medicine.

  • SAIL Records 20.14 MT Steel Sales in FY26

    Steel Authority of India Limited (SAIL) achieved a record 20.14 million tonnes of steel sales in FY26, marking its strongest performance to date.

    The growth was driven by robust demand from construction, automotive, and infrastructure sectors. SAIL’s focus on high-quality products, efficient production, and expanding distribution networks helped meet nationwide industrial needs.

    Beyond volume, the company emphasized sustainable production practices, aligning with environmental goals while supporting India’s economic growth.

    With plans for modernization and capacity expansion, SAIL is well-positioned to maintain momentum and continue contributing to India’s industrial development.

  • Odisha Excels in Urban Water Infrastructure Under AMRUT 2.0

    Odisha has distinguished itself in India under the AMRUT 2.0 program, showcasing excellence in urban water management and infrastructure development. The recognition reflects the state’s dedication to improving water supply, sanitation, and sustainable urban living across its cities.

    Reliable and Accessible Water Supply

    The state’s achievements under AMRUT 2.0 are driven by effective project execution, timely delivery, and expanded tap water services for households in urban areas. Cities have experienced a significant improvement in both the coverage and reliability of piped water, ensuring residents have consistent access to safe drinking water.

    Modern Treatment Facilities and Enhanced Systems

    Odisha has focused on upgrading water treatment plants and distribution systems. The operationalization of advanced treatment facilities, combined with better monitoring and maintenance practices, has improved water quality and reduced losses. These measures ensure urban residents benefit from efficient and high-quality water services.

    A Model for Sustainable Urban Growth

    The state’s success reflects a broader commitment to sustainable urban development and citizen-focused governance. By combining technology, operational efficiency, and strategic planning, Odisha is creating a framework that other regions can emulate.

    Through continued efforts under AMRUT 2.0, Odisha demonstrates how focused infrastructure development and effective implementation can enhance urban living standards, promote sustainability, and ensure access to clean water for all.

  • Two-Wheeler Makers Close FY26 Strong Amid Rural Recovery and Premium Demand

    India’s two-wheeler industry wrapped up the fiscal year 2025-26 on a high note, buoyed by a revival in rural markets and a growing appetite for premium models. Manufacturers reported robust sales across motorcycles, scooters, and high-end bikes, signaling renewed consumer confidence and shifting preferences.

    Rural Markets Drive Growth

    A key factor in the industry’s strong performance has been the resurgence in rural demand. After a period of muted consumption, improved monsoon patterns, higher farm incomes, and targeted financing schemes have encouraged rural consumers to invest in personal mobility. Entry-level motorcycles, especially those priced below ₹80,000, saw healthy uptake, supporting sales volumes for brands catering to tier-2 and tier-3 towns.

    Premium Segment Sees Surge

    While rural recovery drove volume growth, urban markets contributed through heightened demand for premium two-wheelers. Scooters and motorcycles with advanced features, stylish designs, and superior fuel efficiency gained traction among young professionals and aspirational buyers. Electric two-wheelers are also slowly finding a foothold, with government incentives and rising environmental awareness nudging consumers toward sustainable options.

    Strategic Moves by Manufacturers

    Two-wheeler companies leveraged the favorable market environment with aggressive product launches, extended dealer networks, and targeted financing offers. OEMs invested in marketing campaigns highlighting safety, style, and efficiency, while expanding digital sales platforms to tap into tech-savvy buyers. Collaborations with fintech companies for easy loan approvals also played a crucial role in boosting rural demand.

    Industry Outlook

    Industry analysts expect the momentum to continue into FY27. Rural income growth, urban aspirational demand, and rising adoption of premium and electric models are likely to drive further expansion. Manufacturers are also focusing on after-sales service improvements, localized supply chains, and innovation in design and technology to sustain growth in a competitive landscape.

    The combination of robust rural recovery and premium demand not only reinforces India’s position as one of the largest two-wheeler markets in the world but also highlights the evolving dynamics of consumer behavior. The sector’s ability to adapt and innovate will determine how it capitalizes on these trends in the years ahead.

  • India’s Defence Exports Hit Record Rs 38,424 Crore in 2025-26

    India’s defence exports surged to an all-time high of Rs 38,424 crore in 2025-26, marking an impressive 62.7% increase compared to the previous fiscal, according to the latest data from the Ministry of Defence.

    This record growth reflects India’s expanding footprint in the global defence market, driven by a combination of indigenous manufacturing, strategic international partnerships, and a strong push for self-reliance under the “Make in India” initiative. Advanced fighter jets, naval vessels, missile systems, and defence electronics were among the key exports contributing to this surge.

    Officials highlight that the rise in exports not only strengthens India’s defence industry but also enhances strategic ties with partner nations. Several deals signed over the past year, including long-term agreements with Southeast Asia, the Middle East, and Africa, have played a crucial role in this growth.

    The increase in defence exports also has significant economic implications. By promoting domestic manufacturing and boosting foreign revenue, the sector is creating high-value jobs, fostering technological innovation, and reinforcing India’s position as a reliable supplier in the global defence market.

    As India continues to focus on advanced indigenous capabilities and global collaborations, defence exports are expected to remain a key driver of both economic growth and strategic influence in the coming years.

  • India Powers Ahead as a Global Renewable Energy Leader

    India has emerged as the third-largest renewable energy market in the world in 2025, according to the latest report by the International Renewable Energy Agency (IRENA). The country’s rapid expansion in solar, wind, and other clean energy sectors reflects a sustained commitment to reducing carbon emissions and meeting growing energy demand.

    The report highlights India’s remarkable capacity additions over the past year, with solar and wind installations leading the growth. Government policies, investment incentives, and private sector participation have all contributed to this acceleration, making India a key player in the global clean energy transition.

    Experts note that India’s renewable energy surge is not only an environmental achievement but also a strategic economic move. Expanding renewable infrastructure supports energy security, creates jobs, and positions the country as a hub for sustainable technology development.

    With ambitious targets set for 2030, India’s renewable energy journey demonstrates how policy, innovation, and investment can combine to transform the energy landscape. The nation’s success serves as an inspiration for emerging economies seeking to balance growth with sustainability.